The Broad Institute gene-sequencing lab used Roche equipment to read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record.
Q3 2025 Management View CEO Jacob Thaysen reported, "In the third quarter, we delivered another strong performance with ...
Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were ...
Illumina (ILMN) has returned to profitability, reporting high quality earnings and trading at $123.54 per share, which is below its estimated fair value of $166.88. The company is forecasting EPS ...
Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...
US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...
Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ...
Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...
Most biopharma players need access to gene sequencing services. Illumina is facing a handful of headwinds, but it's still the market leader. Bionano Genomics is unproven but expanding quickly. So ...
The move by the commission is seen as a test of regulators’ efforts to prevent big companies from buying small innovators. By Steve Lohr Steve Lohr first wrote about Illumina’s confrontation with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback